Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)
Authors:
- 30 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 15 (5) , 1018-1026
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Crizotinib — Latest Champion in the Cancer Wars?New England Journal of Medicine, 2010
- Biotransformation-mediated synthesis of (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol in enantiomerically pure formTetrahedron: Asymmetry, 2010
- Selective Catalytic Hydrogenation of Functionalized Nitroarenes: An UpdateChemCatChem, 2009
- Mitsunobu and Related Reactions: Advances and ApplicationsChemical Reviews, 2009
- An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic MechanismsCancer Research, 2007
- Preparation and Selective Reactions of Mixed Bimetallic Aromatic and Heteroaromatic Boron–Magnesium ReagentsAngewandte Chemie International Edition, 2005
- How Safe Are Your Reactions?Organic Process Research & Development, 2004
- The Suzuki Reaction with Arylboron Compounds in Arene Chemistry2002
- Sulfonation with Inversion by Mitsunobu Reaction: An Improvement on the Original ConditionsThe Journal of Organic Chemistry, 1996